LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?

Oncology (Williston Park). 2009 Jun;23(7):631-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism

Substances

  • Antineoplastic Agents, Hormonal
  • Gonadotropin-Releasing Hormone